Patents by Inventor Marielle Konig-Schuster

Marielle Konig-Schuster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition effective against viral conjunctivitis
    Patent number: 10220055
    Abstract: The present invention relates to a pharmaceutical composition for use as a medicament in the prophylactic or therapeutic topical treatment of viral eye infections caused by adenovirus of subtype D or influenza A virus of subtype H7. The composition in its ready-for-use formulation comprises iota carrageenan as an active antiviral ingredient and is substantially free of a metal halide salt or contains no more than 0.5% w/v of a metal halide salt.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: March 5, 2019
    Assignee: NICOX S.A.
    Inventors: Eva Prieschl-Grassauer, Martina Morokutti-Kurz, Andreas Grassauer, Sabine Nakowitsch, Angelika Bodenteich, Marielle König-Schuster, Christiane Koller, Frederic Pilotaz
  • Synergistic antiviral composition and use thereof
    Patent number: 10022449
    Abstract: The present invention relates to iota- and/or kappa-carrageenan in combination with a neuraminidase inhibitor for use as a medicament in the prophylactic or therapeutic treatment of a symptom, condition or disease caused by or associated with an infection by an influenza virus.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: July 17, 2018
    Assignee: MARINOMED BIOTECHNOLOGIE GmbH
    Inventors: Andreas Grassauer, Eva Prieschl-Grassauer, Christiane Meier, Marielle Konig-Schuster
  • COMPOSITION EFFECTIVE AGAINST VIRAL CONJUNCTIVITIS
    Publication number: 20160331776
    Abstract: The present invention relates to a pharmaceutical composition for use as a medicament in the prophylactic or therapeutic topical treatment of viral eye infections caused by adenovirus of subtype D or influenza A virus of subtype H7. The composition in its ready-for-use formulation comprises iota carrageenan as an active antiviral ingredient and is substantially free of a metal halide salt or contains no more than 0.5% w/v of a metal halide salt.
    Type: Application
    Filed: January 20, 2015
    Publication date: November 17, 2016
    Inventors: Eva PRIESCHL-GRASSAUER, Martina MOROKUTTI-KURZ, Andreas GRASSAUER, Sabine NAKOWITSCH, Angelika BODENTEICH, Marielle KÖNIG-SCHUSTER, Christiane KOLLER, Frederic PILOTAZ
  • SYNERGISTIC ANTIVIRAL COMPOSITION AND USE THEREOF
    Publication number: 20120302522
    Abstract: The present invention relates to iota- and/or kappa-carrageenan in combination with a neuraminidase inhibitor for use as a medicament in the prophylactic or therapeutic treatment of a symptom, condition or disease caused by or associated with an infection by an influenza virus.
    Type: Application
    Filed: December 17, 2010
    Publication date: November 29, 2012
    Applicant: MARINOMED BIOTECHNOLOGIE GMBH
    Inventors: Andreas Grassauer, Eva Prieschl-Grassauer, Christiane Meier, Marielle Konig-Schuster